Early Infant Diagnosis Point of Care Pilot
Launched by INSTITUTO NACIONAL DE SAÚDE, MOZAMBIQUE · Dec 15, 2015
Trial Information
Current as of April 30, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Born to HIV positive mother
- • From 4 weeks to 18 months of age
- • Came to CCR consultation for Early Infant Diagnosis
- Exclusion Criteria:
- • With a valid positive test by other center
About Instituto Nacional De Saúde, Mozambique
The Instituto Nacional de Saúde (INS) in Mozambique is a leading public health institution dedicated to enhancing health research and promoting evidence-based practices in the country. As a pivotal sponsor of clinical trials, INS plays a crucial role in advancing medical knowledge and improving healthcare outcomes through rigorous scientific investigations. The institute collaborates with national and international partners to address pressing health challenges, focusing on communicable diseases, maternal and child health, and emerging health threats. With a commitment to ethical standards and community engagement, INS strives to ensure that research findings translate into effective public health interventions for the Mozambican population.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Moamba, Maputo, Mozambique
Beira, Sofala, Mozambique
Beira, Sofala, Mozambique
Beira, Sofala, Mozambique
Beira, Sofala, Mozambique
Maputo, , Mozambique
Maputo, , Mozambique
Maputo, , Mozambique
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials